Pravastatin for the Prevention of Preeclampsia in High Risk Women: A Phase I Pilot Study

Northwestern University IRB: STU00202090
Principal Investigators:  Katherine L. Wisner, MD MS (Department of Psychiatry), Catherine Stika, MD (Department of Obstetrics and Gynecology), Alfred George, MD (Department of Pharmacology)

 Why is this research study important?

Preeclampsia is a serious medical condition affecting pregnancy. Certain chemicals in your blood may increase your risk of developing preeclampsia. A medicine called pravastatin, which you take by mouth, may decrease the levels of these chemicals. The purpose of this pilot study is to determine how the body handles Pravastatin during pregnancy and to determine its safety.

You may be eligible to participate if you:

You are not able to participate if you:

What’s involved?

Participants will be compensated:

For more information, please contact Kelly O'Shea at 1-855-99-ASHER, or email kelly.oshea@northwestern.edu